Jiangsu Simcere Pharmaceutical Co., Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Jiangsu Simcere Pharmaceutical Co., Ltd.

29 YRS

Jiangsu, China

CNY 568.8 Million

219780 m²

Over 1000 people

Main Products: Posaconazole / Diosmectite / Zanamivir / Palonosetron Hydrochloride / Pemetrexed Disodium / Bendamustine HCl / Palbociclib / Cabozantinib Malate / Ibrutinib / Edoxaban(Tosylate Monohydrate) / Bedaquiline Fumarate / Apremilast

Jiangsu, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

让患者早日用上更有效药物

Providing Today's Patients with Medicines of the Future

让患者早日用上更有效药物

Providing Today's Patients with Medicines of the Future

让患者早日用上更有效药物

Providing Today's Patients with Medicines of the Future

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturing

Total Employees

1000+ People

Plant Size

330 Acres

Production Experience

29+ Years

Registered Capital

CNY 568.8 Million

MAIN
PRODUCTS

1/3

Posaconazole

CAS: 171228-49-2

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

1/3

Diosmectite

CAS: 1318-93-0

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

1/3

Zanamivir

CAS: 139110-80-8

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

ABOUT US

Jiangsu Simcere Pharmaceutical Co., Ltd.

Jiangsu Xiansheng Pharmaceutical Co., Ltd. is a pharmaceutical company rapidly transforming to innovation and R & D drive. It has been approved by the Ministry of science and technology to build the "State Key Laboratory of translational medicine and innovative drugs". The company focuses on the three major diseases of tumor, central nervous system and autoimmunity, and is committed to "enabling patients to use more effective drugs as soon as possible". With excellent R & D and commercialization capabilities, the main products maintain a leading market share in China. Adhering to the R & D strategy of open innovation, the company has become a strategic partner with a number of multinational companies and biotechnology enterprises to promote the realization of the value of global life science achievements in China. At the same time, the company has ranked among the "top 10 pharmaceutical enterprises with innovative power in China" and "top 100 pharmaceutical industries in China" for many consecutive years.